Reaction

Blood Creatinine Abnormal reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,389 reports · 146 co-occurring drugs

As of the last recalculation, Blood Creatinine Abnormal appears in 3,389 FAERS reports alongside 146 co-occurring drug terms. The strongest observed disproportionality signal is ECULIZUMAB (PRR 28.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Eculizumab	235	28.5	28.6
Fulvestrant	74	14.0	14.1
Voclosporin	18	12.8	12.8
Ribociclib	60	11.9	11.9
Emtricitabine And Tenofovir Alafenamide	21	11.4	11.5
Tenofovir Disoproxil Fumarate	59	11.1	11.2
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide	16	9.8	9.8
Rucaparib	14	9.8	9.8
Cefazolin	14	9.5	9.5
Niraparib	33	9.2	9.2
Mycophenolic Acid	47	9.1	9.1
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate	13	8.9	8.9
Teduglutide	19	8.7	8.7
Emtricitabine And Tenofovir Disoproxil Fumarate	61	8.3	8.4
Nebivolol	21	8.1	8.2
Deferasirox	34	7.9	8.0
Tacrolimus	188	7.7	7.8
Tacrolimus Ointment 0.1%	147	7.5	7.5
Tacrolimus Extended-Release Capsules	147	7.5	7.5
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate	22	7.5	7.5
Dapagliflozin	38	7.5	7.5
Paricalcitol	17	7.4	7.4
Calcitriol Capsules 0.25 Mcg	24	7.4	7.4
Calcitriol Capsules 0.5 Mcg	24	7.4	7.4
Calcitriol	24	7.3	7.3
Anastrozole Tablets	25	7.2	7.2
Cefazolin Sodium	14	7.2	7.2
Everolimus Tablets	19	7.0	7.0
Sennosides 8.6 Mg Tablets	23	6.8	6.8
Senna	23	6.7	6.7
Eplerenone	14	6.7	6.7
Mesna Injection	9	6.7	6.7
Mesna	9	6.6	6.6
Metolazone	12	6.6	6.6
Senna Leaf	24	6.4	6.4
Daspone	10	6.3	6.3
Dapsone Gel, 5%	10	6.3	6.3
Terazosin Hydrochloride	9	6.2	6.2
Dolutegravir Sodium	9	6.1	6.1
Gentamicin	13	6.1	6.1
Bumetanide	26	6.1	6.1
Dronedarone	10	6.0	6.0
Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose	8	6.0	6.0
Daptomycin	9	6.0	6.0
Letrozole Tablets	46	5.9	5.9
Letrozole	58	5.9	5.9
Sodium Bicarbonate	22	5.8	5.8
Sodium Bicarbonate Injection,	22	5.8	5.8
Dapsone	10	5.8	5.8
Fenofibrate	33	5.8	5.8
Alemtuzumab	18	5.7	5.7
Epoetin Alfa	11	5.7	5.7
Erythropoietin	19	5.7	5.7
Nebivolol Hydrochloride	31	5.7	5.7
Dextrose	12	5.6	5.6
Posaconazole Delayed-Release	10	5.6	5.6
Bendamustine Hcl	14	5.6	5.6
Zoledronic Acid	36	5.6	5.6
Dextrose Monohydrate	12	5.5	5.5
Tolvaptan	13	5.5	5.5
Torsemide	28	5.2	5.2
Trimethoprim	10	5.2	5.2
Sennosides	25	5.2	5.2
Febuxostat	14	5.1	5.2
Gentamicin Sulfate	13	5.1	5.1
Rifampin	12	5.1	5.1
Sirolimus	11	5.0	5.0
Anastrozole	29	4.9	4.9
Everolimus	40	4.9	4.9
Insulin Glargine-Yfgn	17	4.8	4.8
Nevirapine	7	4.8	4.8
Mycophenilic Acid	16	4.8	4.8
Agalsidase Beta	7	4.7	4.7
Nilotinib	22	4.6	4.6
Exemestane	16	4.6	4.6
Desloratadine	8	4.6	4.6
Ravulizumab	10	4.6	4.6
Azacitidine For	13	4.4	4.4
Atazanavir	10	4.3	4.3
Lisinopril And Hydrochlorothiazide	7	4.2	4.2
Oxybutynin Chloride	6	4.2	4.2
Posaconazole	11	4.2	4.2
Linezolid	20	4.1	4.1
Lisinopril And Hydrochlorothiazide Tablets	5	3.9	3.9
Venetoclax	37	3.7	3.7
Chlorthalidone	7	3.7	3.7
Pembrolizumab	62	3.7	3.7
Goserelin	8	3.7	3.7
Febuxostat Tablets 40 Mg	6	3.6	3.6
Febuxostat Tablets 80 Mg	6	3.6	3.6
Sunitinib Malate	23	3.6	3.6
Olaparib	12	3.5	3.5
Carvedilol	76	3.5	3.5
Human Insulin	7	3.4	3.4
Ifosfamide	12	3.4	3.4
Lamivudine Oral	14	3.4	3.4
Linagliptin	10	3.4	3.4
Velpatasvir And Sofosbuvir	7	3.4	3.4
Raltegravir	9	3.4	3.4
Azacitidine	16	3.3	3.3
Palbociclib	51	3.3	3.3
Patiromer	7	3.1	3.1
Ruxolitinib	36	3.1	3.1
Encorafenib	5	3.1	3.1
Vemurafenib	6	3.1	3.1
Carfilzomib	14	3.0	3.0
Avapritinib	6	3.0	3.0
Acalabrutinib	6	3.0	3.0
Insulin Glulisine	5	3.0	3.0
Insulin Human	19	2.9	2.9
Sacubitril And Valsartan	55	2.9	2.9
Doxorubicin Hydrochloride	15	2.8	2.8
Alpelisib	4	2.8	2.8
Abemaciclib	9	2.8	2.8
Ibrutinib	36	2.8	2.8
Cisplatin	34	2.7	2.7
Empagliflozin	29	2.7	2.7
Entecavir	5	2.6	2.6
Cabozantinib	20	2.6	2.6
Pazopanib Hydrochloride	11	2.5	2.5
Asfotase Alfa	4	2.5	2.5
Crizotinib	5	2.4	2.4
Lapatinib	6	2.4	2.4
Blinatumomab	4	2.4	2.4
Paclitaxel (Aibumin-Bound)	31	2.3	2.3
Pemetrexed	8	2.3	2.3
Ranitidine Hydrochloride	20	2.3	2.3
Denosumab	70	2.1	2.1
Secukinumab	54	2.1	2.1
Lenvatinib	10	1.9	1.9
Sofosbuvir	6	1.9	1.9
Axicabtagene Ciloleucel	3	1.9	1.9
Eltrombopag Olamine	7	1.9	1.9
Lutetium Lu 177 Vipivotide Tetraxetan	4	1.9	1.9
Relugolix	7	1.8	1.8
Ranolazine	3	1.8	1.8
Dasatinib	10	1.7	1.7
Lenalidomide	112	1.6	1.6
Canagliflozin	8	1.6	1.6
Sevelamer Carbonate	3	1.6	1.6
Tafamidis	3	1.6	1.6
Ixazomib	7	1.5	1.5
Pomalidomide	20	1.2	1.2
Osimertinib	6	1.1	1.1
Droxidopa	3	0.9	0.9
Cinacalcet Hydrochloride	5	0.7	0.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.